Search - tctmd.com

Displaying 801 - 820 of 826

Sort: Relevancy | Date

News Daily News

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Leah Lawrence

April 26, 2011

News Daily News

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

April 20, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

L.A. McKeown

April 05, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

April 04, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Daily News

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

March 21, 2011

News Daily News

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

Caitlin E. Cox

March 16, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

News Daily News

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Jason Kahn

February 23, 2011

News Daily News

Paclitaxel-Eluting Balloon Effective for DES Restenosis

February 22, 2011

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Leah Lawrence

February 03, 2011

News Daily News

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

L.A. McKeown

January 24, 2011

Advertisement

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

Therapies Take on In-Stent Restenosis with Mixed Results

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Paclitaxel-Eluting Balloon Effective for DES Restenosis

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content